v3 Template
K

Karyopharm Therapeutics Inc.

Pharmaceuticals / Biotechnology Newton, Mass. ~360 employees
Founded
--
Employees (Est.)
~360
18 leaders known
Total Funding
$130.0M
Funding Rounds
2
Last Funding
2026-03-24

About Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company dedicated to pioneering novel cancer therapies. Their mission is fueled by a belief in the extraordinary strength and courage of patients with cancer, driving their commitment to scientific innovation and patient care.

Products & Services

Cancer Therapies:Novel therapies targeting high unmet needs in cancer treatment, including hematologic and solid tumors.
XPO1 Inhibition & SINE Technology:Industry-leading oral Selective Inhibitor of Nuclear Export (SINE) technology addressing oncogenesis, the process of healthy cells transforming into cancer cells.

Specialties

Cancer Therapies XPO1 Inhibition Selective Inhibitor of Nuclear Export (SINE) Technology Oncogenesis Research Clinical Trials in Hematologic and Solid Tumors oral Selective Inhibitor of Nuclear Export (SINE) technology XPO1 inhibition novel cancer therapies for hematologic and solid tumors

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Private Placement
T: -
FT: Private Placement
A: 30000000
MR: -
FA: approximately $30 million
FAN: 30000000
D: 2026-03-24
FD: 2026-03-24
1 investors
2 RT: Strategic Financing
T: -
FT: Strategic Financing
A: 100000000
MR: -
FA: $100 million
FAN: 100000000
D: 2025-10-08
FD: 2025-10-08
3 investors
Private Placement Latest
2026-03-24
$30.0M
1 investor (Pro only)
Strategic Financing 2025-10-08
$100.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Richard Paulson

President and Chief Executive Officer

J

James Accumanno

Chief Compliance Officer

B

Brian Austad

Senior Vice President, Pharmaceutical Sciences

S

Sohanya Cheng

Chief Commercial Officer and Head of Business Development

L

Lisa DiPaolo

Chief Human Resources Officer

L

Lori Macomber

Executive Vice President, Chief Financial Officer and Treasurer

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Karyopharm Therapeutics Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Pharmaceuticals / Biotechnology
Company Size
~360 employees (est.)
Locations
Newton, Mass.
NEWTON, Mass.

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro